Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women, JAMA, vol.301, issue.5, pp.513-534, 2009. ,
DOI : 10.1001/jama.2009.50
Health-Related Quality of Life in Postmenopausal Women With Low BMD With or Without Prevalent Vertebral Fractures, Journal of Bone and Mineral Research, vol.50, issue.Suppl, pp.1384-92, 2000. ,
DOI : 10.1359/jbmr.2000.15.7.1384
Population-Based Study of Survival after Osteoporotic Fractures, American Journal of Epidemiology, vol.137, issue.9, pp.1001-1006, 1993. ,
DOI : 10.1093/oxfordjournals.aje.a116756
Risk of Mortality Following Clinical Fractures, Osteoporosis International, vol.11, issue.7, pp.556-61, 2000. ,
DOI : 10.1007/s001980070075
The Epidemiology and Pathogenesis of Osteoporosis, Inc, 2000. ,
Changes in number and incidence of hip fractures over 12years in France, Bone, vol.81, pp.131-138, 2015. ,
DOI : 10.1016/j.bone.2015.07.009
Epidemiology of osteoporosisrelated fractures in France: a literature review, Jt Bone Spine Rev Rhum, 2010. ,
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.3, pp.304-317 ,
DOI : 10.1016/j.jbspin.2012.02.014
Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. Drugs, pp.65-78, 2011. ,
Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study, Osteoporosis International, vol.24, issue.9, pp.2551-2557, 2011. ,
DOI : 10.1007/s00198-010-1444-6
Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture, N Engl J Med, vol.357, p.40967, 2007. ,
Continuing Bisphosphonate Treatment for Osteoporosis ??? For Whom and for How Long?, New England Journal of Medicine, vol.366, issue.22, 2015. ,
DOI : 10.1056/NEJMp1202623
Effects of Continuing or Stopping Alendronate After 5 Years of Treatment, JAMA, vol.296, issue.24, pp.2927-2965, 2006. ,
DOI : 10.1001/jama.296.24.2927
Evaluation of Osteoporosis Treatment in Seniors after Hip Fracture, Osteoporosis International, vol.13, issue.3, pp.205-215, 2002. ,
DOI : 10.1007/s001980200015
Underutilization of Calcium and Vitamin D Supplements in an Academic Long-Term Care Facility, Journal of the American Medical Directors Association, vol.5, issue.2, pp.98-100 ,
DOI : 10.1016/S1525-8610(04)70062-6
The Underuse of Therapy in the Secondary Prevention of Hip Fractures. Drugs Aging, pp.1-10, 2002. ,
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture, J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis, vol.20, issue.6, pp.347-355, 2014. ,
Underuse in Elderly Adults: An Underestimated Suboptimal Prescribing, Journal of the American Geriatrics Society, vol.59, issue.8, pp.1582-1585, 2012. ,
DOI : 10.1111/j.1532-5415.2012.04071.x
Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum, 2006. ,
Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture, The American Journal of Medicine, vol.109, issue.4, 2000. ,
DOI : 10.1016/S0002-9343(00)00457-5
Undertreatment of osteoporosis following hip fracture in the elderly, Archives of Gerontology and Geriatrics, vol.49, issue.1, 2009. ,
DOI : 10.1016/j.archger.2008.06.007
Antiosteoporosis drug prescribing after hip fracture in the UK: 2000-2010, Osteoporos Int J Establ Result, 2015. ,
Correlations of nursing home characteristics with prescription of osteoporosis medications, Bone, vol.48, issue.5, pp.1164-1172, 2011. ,
DOI : 10.1016/j.bone.2011.02.006
Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing, vol.43, issue.6, pp.744-751, 2014. ,
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture, Osteoporosis International, vol.165, issue.20, pp.553-562, 2007. ,
DOI : 10.1007/s00198-006-0260-5
Adh??rence, observance, persistance, concordance??: prenons-nous en??charge correctement nos patientes ost??oporotiques???, Revue du Rhumatisme, vol.73, issue.9, pp.1-9, 2006. ,
DOI : 10.1016/j.rhum.2005.09.015
Pr??vention secondaire de??l'ost??oporose fracturaire: r??sultats ????un??an d'une fili??re de??prise en??charge des??patients fractur??s, Revue du Rhumatisme, vol.73, issue.10-11, pp.10-111140, 2006. ,
DOI : 10.1016/j.rhum.2006.10.315
Vitamine D??: effet osseux et extra-osseux??; recommandations de bon usage, Presse Médicale, 2009. ,
DOI : 10.1016/j.lpm.2008.08.008
Vitamine D chez la personne âgée : pourquoi ? Quand ? Comment ? Nutr Clin Métabolisme, pp.123-132, 2014. ,
MMS : Caractéristiques de déplacement : -Marche (sans aide, avec cannes, avec déambulateur) -Avec fauteuil roulant -Confinement au lit et au fauteuil GIR ,